Evaluation of Safety and Efficacy of Bixdo Ultra Compact Water Flosser
ConditionPlaque Induced Gingivitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorTufts University
About this trial
The objective of the present randomized controlled trial is to evaluate the safety and efficacy of the use of Bixdo A30 Pro Ultra Compact Water Flosser (also referred to as the "Bixdo A30 Portable Water Flosser Travel Set") in addition to a manual toothbrush on clinical parameters of inflammation and bacterial plaque removal.
Eligibility criteria
Qualifiers
Participants between the age of 18 - 70 years old.
Having at least 20 natural teeth in their dentition - excluding third molars.
In good overall systemic health, in the opinion of the investigator.
In good dental health with no visible carious lesions, periodontitis, orthodontic appliances, or removable partial dentures.
Disqualifiers
Systemic disease self-reported that has an impact on periodontal status (e.g., diabetes mellitus, HIV/AIDS, rheumatoid arthritis).
History of any autoimmune disease (e.g., pSS, SLE, psoriasis, IBS).
History of immunosuppressive chemotherapy or history of any disease known to severely compromise immune function (e.g., cytomegalovirus infection) within the last 5 years.
Any acute intraoral infection (e.g., herpetic gingivostomatitis, herpangina, abscesses).
Trial design
Treatments tested in this trial
- Bixdo Ultra Compact Water Flosser
- Manual toothbrush
Treatment groups
165 Participants
are divided into 2 treatment groupsSponsors and collaborators
Tufts University
Lead sponsor
Guang Dong Bixdo Health Technology Co.,Ltd
Collaborator
Source ClinicalTrials.gov